Skip to main content
Top
Published in: Diabetology International 1/2022

01-01-2022 | Obesity | Original Article

Cut-off values and clinical efficacy of body roundness index and other novel anthropometric indices in identifying metabolic syndrome and its components among Southern-Indian adults

Authors: Chiranjeevi Kumar Endukuru, Girwar Singh Gaur, Yerrabelli Dhanalakshmi, Jayaprakash Sahoo, Balasubramaniyan Vairappan

Published in: Diabetology International | Issue 1/2022

Login to get access

Abstract

Context

Abdominal obesity (AO) is a definitive link between cardiometabolic complications and metabolic syndrome (MetS). Many traditional and novel anthropometric indices have been identified to determine AO, and their relationship to MetS has been investigated. However, whether these indices are useful in a clinical setting is unknown. Moreover, the cut-off points for these indices to determine MetS have yet to be defined among Southern-Indian adults.

Aims

We aimed to evaluate the cut-off values and clinical efficacy of novel anthropometric indices in identifying MetS and its components.

Materials and methods

Subjects (n = 202) were recruited and then grouped into cases (MetS = 106) and controls (healthy = 96). We measured anthropometric data and assayed glycemic and lipid profiles. Using these, we computed a-body shape index (ABSI), abdominal volume index (AVI), body adiposity index (BAI), body roundness index (BRI), conicity index (CI), lipid-accumulation product (LAP), visceral adiposity index (VAI) and waist-triglyceride index (WTI) from published equations.

Results

Compared to the control group, all the novel anthropometric indices were noticeably higher in both male and female subjects of the MetS group. The area under the curve values (AUCs) demonstrated that BRI, CI, AVI, and WTI had superior detection power in identifying MetS, and the AUCs varied upon stratification by gender. BRI was strongly associated with the highest odds of having MetS (OR 66.03).

Conclusions

The optimal cut-off and AUC values attained for BRI, CI, AVI, and WTI have a clinical approach in identifying MetS and its components. The efficacy of these indices to identify MetS differed by gender.
Literature
1.
go back to reference Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):e177-232.CrossRef Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):e177-232.CrossRef
2.
go back to reference Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769–78.CrossRef Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769–78.CrossRef
3.
go back to reference Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375(9710):181–3.CrossRef Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375(9710):181–3.CrossRef
4.
go back to reference Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629–36.CrossRef Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629–36.CrossRef
5.
go back to reference Zafar U, Khaliq S, Ahmad HU, Manzoor S, Lone KP. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links. Hormones. 2018;17(3):299–313.CrossRef Zafar U, Khaliq S, Ahmad HU, Manzoor S, Lone KP. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links. Hormones. 2018;17(3):299–313.CrossRef
7.
go back to reference Saklayen MG. The global epidemic of metabolic syndrome. Curr Hypertens Rep. 2018;20:12.CrossRef Saklayen MG. The global epidemic of metabolic syndrome. Curr Hypertens Rep. 2018;20:12.CrossRef
8.
go back to reference Bhowmik B, Afsana F, Siddiquee T, Munir SB, Sheikh F, Wright E, et al. Comparison of the prevalence of metabolic syndrome and its association with diabetes and cardiovascular disease in the rural population of Bangladesh using the modified National Cholesterol Education Program Expert Panel Adult Treatment Panel III and International Diabetes Federation definitions. J Diabetes Investig. 2015;6(3):280–8.CrossRef Bhowmik B, Afsana F, Siddiquee T, Munir SB, Sheikh F, Wright E, et al. Comparison of the prevalence of metabolic syndrome and its association with diabetes and cardiovascular disease in the rural population of Bangladesh using the modified National Cholesterol Education Program Expert Panel Adult Treatment Panel III and International Diabetes Federation definitions. J Diabetes Investig. 2015;6(3):280–8.CrossRef
9.
go back to reference Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATP III and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127–34.CrossRef Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATP III and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127–34.CrossRef
10.
go back to reference Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban Eastern India. J Cardiovasc Dis Res. 2012;3(3):204.CrossRef Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban Eastern India. J Cardiovasc Dis Res. 2012;3(3):204.CrossRef
12.
go back to reference Shin J-A, Lee J-H, Lim S-Y, Ha H-S, Kwon H-S, Park Y-M, et al. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig. 2013;4(4):334–43.CrossRef Shin J-A, Lee J-H, Lim S-Y, Ha H-S, Kwon H-S, Park Y-M, et al. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig. 2013;4(4):334–43.CrossRef
13.
go back to reference Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–49.CrossRef Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–49.CrossRef
14.
go back to reference Cai L, Lubitz J, Flegal KM, Pamuk ER. The predicted effects of chronic obesity in middle age on medicare costs and mortality. Med Care. 2010;1:510–7.CrossRef Cai L, Lubitz J, Flegal KM, Pamuk ER. The predicted effects of chronic obesity in middle age on medicare costs and mortality. Med Care. 2010;1:510–7.CrossRef
15.
go back to reference World Health Organization. Obesity: preventing and managing the global epidemic. World Health Org Tech Rep Ser. 2000;894:1–253. World Health Organization. Obesity: preventing and managing the global epidemic. World Health Org Tech Rep Ser. 2000;894:1–253.
17.
go back to reference Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13:275–86.CrossRef Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13:275–86.CrossRef
18.
go back to reference Ma CM, Lu N, Wang R, Liu XL, Lu Q, Yin FZ. Three novel obese indicators perform better in monitoring the management of metabolic syndrome in type 2 diabetes. Sci Rep. 2017;7:9843.CrossRef Ma CM, Lu N, Wang R, Liu XL, Lu Q, Yin FZ. Three novel obese indicators perform better in monitoring the management of metabolic syndrome in type 2 diabetes. Sci Rep. 2017;7:9843.CrossRef
19.
go back to reference Costa EC, Sa JC, Soares EM, Lemos TM, Maranhao TM, Azevedo GD. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome. Gynecol Endocrinol. 2012;28:12–5.CrossRef Costa EC, Sa JC, Soares EM, Lemos TM, Maranhao TM, Azevedo GD. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome. Gynecol Endocrinol. 2012;28:12–5.CrossRef
20.
go back to reference Motamed N, Sohrabi M, Poustchi H, Maadi M, Malek M, Keyvani H, et al. The six obesity indices, which one is more compatible with metabolic syndrome? A population-based study. Diabetes Metab Syndr. 2017;11(3):173–7.CrossRef Motamed N, Sohrabi M, Poustchi H, Maadi M, Malek M, Keyvani H, et al. The six obesity indices, which one is more compatible with metabolic syndrome? A population-based study. Diabetes Metab Syndr. 2017;11(3):173–7.CrossRef
21.
go back to reference Thomas DM, Bredlau C, Bosy-Westphal A, Mueller M, Shen W, Gallagher D, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity. 2013;21(11):2264–71.CrossRef Thomas DM, Bredlau C, Bosy-Westphal A, Mueller M, Shen W, Gallagher D, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity. 2013;21(11):2264–71.CrossRef
22.
go back to reference Liu B, Liu B, Wu G, Yin F. Relationship between body-roundness index and metabolic syndrome in type 2 diabetes. Diabetes Metab Syndr Obes Targets Ther. 2019;12:931–5.CrossRef Liu B, Liu B, Wu G, Yin F. Relationship between body-roundness index and metabolic syndrome in type 2 diabetes. Diabetes Metab Syndr Obes Targets Ther. 2019;12:931–5.CrossRef
23.
go back to reference WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1–452. WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1–452.
24.
go back to reference Fukuyama N, Homma K, Wakana N, Kudo K, Suyama A, Ohazama H, Tsuji C, Ishiwata K, Eguchi Y, Nakazawa H, Tanaka E. Validation of the friedewald equation for evaluation of plasma LDL-cholesterol. J Clin Biochem Nutr. 2008;43(1):1–5.CrossRef Fukuyama N, Homma K, Wakana N, Kudo K, Suyama A, Ohazama H, Tsuji C, Ishiwata K, Eguchi Y, Nakazawa H, Tanaka E. Validation of the friedewald equation for evaluation of plasma LDL-cholesterol. J Clin Biochem Nutr. 2008;43(1):1–5.CrossRef
25.
go back to reference Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.CrossRef Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.CrossRef
26.
go back to reference Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care. 2006;29(1):151–3.CrossRef Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care. 2006;29(1):151–3.CrossRef
27.
go back to reference Yang RF, Liu XY, Lin Z, Zhang G. Correlation study on waist circumference-triglyceride (WT) index and coronary artery scores in patients with coronary heart disease. Eur Rev Med Pharmacol Sci. 2015;19(1):113–8.PubMed Yang RF, Liu XY, Lin Z, Zhang G. Correlation study on waist circumference-triglyceride (WT) index and coronary artery scores in patients with coronary heart disease. Eur Rev Med Pharmacol Sci. 2015;19(1):113–8.PubMed
28.
go back to reference Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7(7):e39504.CrossRef Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7(7):e39504.CrossRef
29.
go back to reference Guerrero-Romero F, Rodrı́guez-Morán F. Abdominal volume index. An anthropometry-based index for the estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Arch Med Res. 2003;34(5):428–32.CrossRef Guerrero-Romero F, Rodrı́guez-Morán F. Abdominal volume index. An anthropometry-based index for the estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Arch Med Res. 2003;34(5):428–32.CrossRef
30.
go back to reference Farzad S, Fatemeh A, Salehi M, Nojomi M. Association of waist circumference, body mass index and conicity index with cardiovascular risk factors in postmenopausal women. Cardiovasc J Afr. 2012;23(8):442.CrossRef Farzad S, Fatemeh A, Salehi M, Nojomi M. Association of waist circumference, body mass index and conicity index with cardiovascular risk factors in postmenopausal women. Cardiovasc J Afr. 2012;23(8):442.CrossRef
31.
go back to reference Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG, Xiang AH, Watanabe RM. A better index of body adiposity. Obesity. 2011;19(5):1083–9.CrossRef Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG, Xiang AH, Watanabe RM. A better index of body adiposity. Obesity. 2011;19(5):1083–9.CrossRef
32.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics. 1988;1:837–45.CrossRef DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics. 1988;1:837–45.CrossRef
33.
go back to reference Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF. Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J. 2008;50(3):419–30.CrossRef Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF. Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J. 2008;50(3):419–30.CrossRef
37.
go back to reference López AA, Cespedes ML, Vicente T, Tomas M, Bennasar-Veny M, Tauler P, Aguilo A. Body adiposity index utilization in a Spanish Mediterranean population: comparison with the body mass index. PLoS One. 2012;7(4):e35281.CrossRef López AA, Cespedes ML, Vicente T, Tomas M, Bennasar-Veny M, Tauler P, Aguilo A. Body adiposity index utilization in a Spanish Mediterranean population: comparison with the body mass index. PLoS One. 2012;7(4):e35281.CrossRef
38.
go back to reference Shin KA, Hong SB, Shin KS. Body adiposity index and metabolic syndrome risk factors in Korean adults: a comparison with bodymass index and other parameters. Biomed Sci Lett. 2017;23:57–63.CrossRef Shin KA, Hong SB, Shin KS. Body adiposity index and metabolic syndrome risk factors in Korean adults: a comparison with bodymass index and other parameters. Biomed Sci Lett. 2017;23:57–63.CrossRef
39.
go back to reference Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5(1):26.CrossRef Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5(1):26.CrossRef
40.
go back to reference Mirmiran P, Bahadoran Z, Azizi F. Lipid accumulation product is associated with insulin resistance, lipid peroxidation, and systemic inflammation in type 2 diabetic patients. Endocrinol Metab. 2014;29(4):443–9.CrossRef Mirmiran P, Bahadoran Z, Azizi F. Lipid accumulation product is associated with insulin resistance, lipid peroxidation, and systemic inflammation in type 2 diabetic patients. Endocrinol Metab. 2014;29(4):443–9.CrossRef
41.
go back to reference Amato MC, Giordano C, Galia M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.CrossRef Amato MC, Giordano C, Galia M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.CrossRef
42.
go back to reference Wang Y, He S, He J, Wang S, Liu K, Chen X. Predictive value of visceral adiposity index for type 2 diabetes mellitus. Herz. 2015;40(3):277–81.CrossRef Wang Y, He S, He J, Wang S, Liu K, Chen X. Predictive value of visceral adiposity index for type 2 diabetes mellitus. Herz. 2015;40(3):277–81.CrossRef
43.
go back to reference Chen HY, Chiu YL, Chuang YF, Hsu SP, Pai MF, Yang JY, Peng YS. Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients. Cardiovasc Diabetol. 2014;13(1):136.CrossRef Chen HY, Chiu YL, Chuang YF, Hsu SP, Pai MF, Yang JY, Peng YS. Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients. Cardiovasc Diabetol. 2014;13(1):136.CrossRef
44.
go back to reference Bermúdez VJ, Salazar J, Añez R, Rivas-Ríos JR, Chávez-Castillo M, Torres W, Núñez V, Mejías J, Wilches-Durán S, Cerda M, Graterol M. Optimal cut-off for visceral adiposity index in a Venezuelan population: results from the Maracaibo City Metabolic Syndrome Prevalence Study. Rev Argent Endocrinol Metab. 2017;54(4):176–83. Bermúdez VJ, Salazar J, Añez R, Rivas-Ríos JR, Chávez-Castillo M, Torres W, Núñez V, Mejías J, Wilches-Durán S, Cerda M, Graterol M. Optimal cut-off for visceral adiposity index in a Venezuelan population: results from the Maracaibo City Metabolic Syndrome Prevalence Study. Rev Argent Endocrinol Metab. 2017;54(4):176–83.
46.
go back to reference Baveicy K, Mostafaei S, Darbandi M, Hamzeh B, Najafi F, Pasdar Y. Predicting metabolic syndrome by visceral adiposity index, body roundness index and a body shape index in adults: a cross-sectional study from the Iranian RaNCD cohort data. Diabetes Metab Syndr Obes Targets Ther. 2020;13:879.CrossRef Baveicy K, Mostafaei S, Darbandi M, Hamzeh B, Najafi F, Pasdar Y. Predicting metabolic syndrome by visceral adiposity index, body roundness index and a body shape index in adults: a cross-sectional study from the Iranian RaNCD cohort data. Diabetes Metab Syndr Obes Targets Ther. 2020;13:879.CrossRef
Metadata
Title
Cut-off values and clinical efficacy of body roundness index and other novel anthropometric indices in identifying metabolic syndrome and its components among Southern-Indian adults
Authors
Chiranjeevi Kumar Endukuru
Girwar Singh Gaur
Yerrabelli Dhanalakshmi
Jayaprakash Sahoo
Balasubramaniyan Vairappan
Publication date
01-01-2022
Publisher
Springer Singapore
Keywords
Obesity
Obesity
Published in
Diabetology International / Issue 1/2022
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-021-00522-5

Other articles of this Issue 1/2022

Diabetology International 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.